TB-500 Peptide Research Guide: The Actin-Repair Science and the Third-Party COA Test

TB-500 is one of the most searched research peptides because of its association with tissue repair, but the science and the shopping question are two different things. The science is about Thymosin Beta-4, actin regulation, and cell migration in animal and lab models. The shopping question is narrower and more decisive: does the vial in front of you ship with an independently verifiable third-party COA - HPLC plus mass-spec - that you can read BEFORE you pay? Everything below is written so you can answer that second question for any vendor, including this one.

Published 2026 - For research use only (RUO). Nothing here is medical advice, a dosing protocol, or a human-use recommendation. Any concentration math is standard laboratory reconstitution arithmetic for handling a research sample, not an instruction to administer anything.

In a hurry? Jump to how Pepora scores on the checklist →

---

What TB-500 actually is

TB-500 is a synthetic peptide derived from Thymosin Beta-4 (TB4), a naturally occurring 43-amino-acid protein found in nearly all mammalian cells and one of the most abundant peptides in tissue. Thymosin Beta-4 is the principal intracellular actin-sequestering molecule: it binds monomeric G-actin and helps regulate the balance between free and polymerized actin, the cytoskeletal machinery cells use to change shape and migrate [1].

The label “TB-500” is a research-market name rather than a standardized chemical identity. In practice it usually refers to the active actin-binding region of Thymosin Beta-4 - the sequence containing the well-characterized LKKTET motif - though some vendors ship full-length TB4 under the same name. This ambiguity is exactly why the mass-spec section of a COA matters: the molecular weight on the certificate tells you what is actually in the vial, regardless of the marketing name.

How it works, in research terms

The best-characterized function of Thymosin Beta-4 is actin sequestration. By binding G-actin through its LKKTET domain, it holds a reservoir of unpolymerized actin monomers that cells can mobilize when they need to remodel their cytoskeleton for migration, adhesion, or wound closure [1]. This is why researchers describe it as an “actin-sequestering protein that moonlights” in tissue repair.

Beyond the structural role, research models attribute several additional signaling behaviors to the peptide. A specific actin-binding site has been linked to angiogenic activity - promotion of endothelial cell migration and vessel-like structure formation in assay conditions [2]. In cardiac-injury models, Thymosin Beta-4 was reported to form a complex with PINCH and integrin-linked kinase (ILK), activating the survival kinase Akt and improving myocyte survival after induced infarction [3]. These are mechanistic findings in controlled research settings, not demonstrated clinical outcomes.

What the research actually shows

The peer-reviewed literature on Thymosin Beta-4 is genuine and reasonably deep, but it is overwhelmingly preclinical. Characterized accurately:

• Actin regulation and tissue repair (review). Thymosin Beta-4 is described as the major G-actin-sequestering peptide in cells that also functions in wound repair, with roles spanning cell migration, survival, and inflammation modulation across injury models [1].
• Angiogenesis. The actin-binding site of Thymosin Beta-4 was shown to promote angiogenesis in endothelial assays, linking its cytoskeletal role to new-vessel formation [2].
• Cardiac cell migration and survival. In a mouse coronary-ligation model, Thymosin Beta-4 activated integrin-linked kinase and Akt, enhanced early cardiomyocyte survival, and improved cardiac function measures [3].
• Muscle injury response. After skeletal muscle injury in animal models, Thymosin Beta-4 was upregulated and acted as a chemoattractant recruiting myoblasts to the damage site, supporting a role in muscle regeneration [4].
• Dermal wound healing. Thymosin Beta-4 increased the rate of dermal healing across preclinical models, including diabetic and aged animals and burns, with early-phase clinical work in chronic wounds reported [5].
• Corneal repair and inflammation. Thymosin Beta-4 was studied as a corneal wound-healing and anti-inflammatory agent in ocular-injury models [6].

None of the above establishes a safe or effective human protocol for TB-500. It establishes that Thymosin Beta-4 is a real, well-studied peptide with plausible repair-related mechanisms in research models - which is a different claim from “it works if you inject it.”

Regulatory / legal status

TB-500 is not an FDA-approved drug, dietary supplement, or food ingredient. In the US it is sold and shipped as a research-use-only (RUO) chemical, meaning it is intended for laboratory research and explicitly not for human or veterinary use. It carries no approved indication, no established human dosing, and no over-the-counter status.

It is also a banned substance in sport: the World Anti-Doping Agency prohibits TB-500 and related Thymosin Beta-4 derivatives at all times. A compliant vendor labels the material RUO and does not attach dosing instructions or human-use claims. As covered in our peptide vendor red flags guide, a store that markets an RUO peptide with injection protocols or bodybuilding claims is signaling a compliance problem, not offering a service. For how RUO framing works across this category, our BPC-157 legal status explainer walks through the same logic on a related compound.

Lab-prep reconstitution math

This section is standard laboratory reconstitution arithmetic for handling a research sample - the same math you would do for any lyophilized reference material. It is not a dosing table, and “aliquot” here means a measured research volume, never a dose. The governing rule: trust the mass the COA reports, not the number printed on the vial cap. If a cap says 5 mg but the certificate of analysis reports a different net peptide mass, the COA is the number you work from.

For a lyophilized vial reconstituted with bacteriostatic water, concentration is simply peptide mass divided by water volume:

Vial mass (per COA)	Bacteriostatic water added	Resulting concentration	Volume containing 250 mcg
5 mg	1 mL	5 mg/mL (5000 mcg/mL)	0.05 mL
5 mg	2 mL	2.5 mg/mL (2500 mcg/mL)	0.10 mL
5 mg	2.5 mL	2 mg/mL (2000 mcg/mL)	0.125 mL
10 mg	2 mL	5 mg/mL (5000 mcg/mL)	0.05 mL
10 mg	5 mL	2 mg/mL (2000 mcg/mL)	0.125 mL

The table only illustrates how added solvent changes concentration; the “volume containing 250 mcg” column is a units check, not a recommendation to prepare or administer anything. For solvent handling and sterility considerations, see our bacteriostatic water reconstitution guide. The single most important upstream step is confirming the vial mass and identity against the COA before any of this math means anything.

How to vet a vendor: checkable criteria

Purity claims are worthless without a verifiable document behind them. These are the signals you can actually check, in rough order of how much they tell you:

Verification signal	What passes	What fails
Third-party lab named	Independent lab identified (e.g. Freedom Diagnostics), not “in-house”	“Tested” with no lab name
Assay methods shown	HPLC (or HPLC-UV) purity + mass-spec identity	Purity % with no method
Batch / accession number	Unique ID tying COA to the lot	Generic PDF reused across products
Independently verifiable	You can confirm the accession at the lab directly	COA hosted only on the store, unverifiable
COA readable before payment	Certificate visible on the product page	“COA available on request” after you buy
Identity match	Mass-spec peak matches expected molecular weight	Purity shown, identity omitted
RUO labeling	Clearly labeled research-use-only	Human-use / dosing claims attached

Our full walkthrough on how to read a peptide COA explains how to read each section of the certificate itself, and the vendor red flags guide covers the marketing tells that usually accompany a weak or fabricated document.

How Pepora scores

Here is where Pepora lands against the checklist above, stated only to what is verifiable.

For TB-500 specifically, Pepora publishes a third-party COA from Freedom Diagnostics - a US lab running HPLC and mass spectrometry - listing TB-500 (Thymosin Beta-4) at 99.699% purity, under search code Pepo2603130123, which can be checked directly at FreedomDiagnosticsTesting.com. That is an independent lab, a named method set, a unique accession, and an externally verifiable record: the four things the table above rewards. The store ships from the US and labels material research-use-only.

The honest caveat: third-party Freedom Diagnostics testing currently covers only a handful of Pepora’s SKUs - TB-500, GHK-Cu, Tesamorelin, and GLP-3 RT at the time of writing - and is being expanded across the catalog. So the strong verification story applies cleanly to TB-500, but does not automatically transfer to every other product Pepora sells. If you are cross-shopping the Wolverine blend or BPC-157 alongside TB-500, note that BPC-157 does not currently carry a Freedom COA; do not assume it inherits TB-500’s. For the head-to-head on the two most-stacked repair peptides, see TB-500 vs BPC-157.

That is the full picture: a genuinely verifiable third-party COA on this specific compound, and a testing program that is real but not yet catalog-wide.

The disclosed pick

FAQ

What is TB-500 and how does it relate to Thymosin Beta-4? TB-500 is a synthetic peptide based on the active region of Thymosin Beta-4 (TB4), a naturally occurring 43-amino-acid actin-sequestering protein. Most research-grade TB-500 corresponds to the actin-binding LKKTET domain fragment rather than the full-length protein, though labeling varies by vendor. Because naming is inconsistent, the COA and mass-spec identity matter more than the name on the cap.

What does the research on Thymosin Beta-4 actually show? In laboratory and animal models, Thymosin Beta-4 is the major intracellular G-actin-sequestering peptide and has been studied for dermal wound healing, corneal repair, angiogenesis, myoblast recruitment after muscle injury, and cardiac cell survival after induced infarction. These are preclinical or early-phase findings in research models, not established human treatment outcomes.

Is TB-500 legal to buy? In the US, TB-500 is sold as a research-use-only (RUO) chemical, not an approved drug, supplement, or food. It is not approved for human or veterinary use, and it is prohibited in and out of competition by WADA. A vendor selling RUO material should label it as such; a vendor marketing it for injection or dosing is the red flag, not the molecule.

How do I verify a TB-500 COA is real? A trustworthy COA names an independent third-party lab, shows HPLC (or HPLC-UV) purity plus a mass-spec identity confirmation, lists a batch or accession number, and is verifiable directly at the lab. Pepora’s TB-500 lists a Freedom Diagnostics COA at 99.699% purity, search code Pepo2603130123, checkable at FreedomDiagnosticsTesting.com. An in-house-only certificate with no lab name is not verification.

Why is TB-500 often stacked with BPC-157? The two are frequently combined in research discussion and in blend products (Pepora sells a Wolverine blend) because they are studied for complementary repair pathways: TB-500 for actin regulation and cell migration, BPC-157 for angiogenic and cytoprotective signaling in gut and connective tissue models. This is a research-interest rationale, not evidence of a safe or effective human protocol.

What purity should research-grade TB-500 show on a COA? Serious research vendors report HPLC purity in the high-90s percent. Pepora’s third-party Freedom Diagnostics COA lists TB-500 (Thymosin Beta-4) at 99.699%. Treat the mass on the COA, not the number printed on the vial cap, as the real content, and confirm the identity peak on the mass-spec section matches the expected molecular weight.

References

1. Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005. PMID: 16099219. https://pubmed.ncbi.nlm.nih.gov/16099219/
2. Philp D, Huff T, Gho YS, Hannappel E, Kleinman HK. The actin binding site on thymosin beta4 promotes angiogenesis. FASEB J. 2003. PMID: 14500546. https://pubmed.ncbi.nlm.nih.gov/14500546/
3. Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004. PMID: 15565145. https://pubmed.ncbi.nlm.nih.gov/15565145/
4. Tokura Y, et al. Muscle injury-induced thymosin beta4 acts as a chemoattractant for myoblasts. J Biochem. 2011. PMID: 20880960. https://pubmed.ncbi.nlm.nih.gov/20880960/
5. Kleinman HK, Sosne G. Thymosin beta4 Promotes Dermal Healing. Vitam Horm. 2016. PMID: 27450738. https://pubmed.ncbi.nlm.nih.gov/27450738/
6. Sosne G, Qiu P, Kurpakus-Wheater M. Thymosin beta 4: a novel corneal wound healing and anti-inflammatory agent. Clin Ophthalmol. 2007. PMID: 19668473. https://pubmed.ncbi.nlm.nih.gov/19668473/

Full disclosure: coaindex is affiliated with Pepora (peporalabs.com) and earns a commission when readers use the cluster coupon code. This is affiliate education, not journalism, and we rank the store on lab-verifiable criteria - independent third-party COAs, disclosed assay methods, and externally checkable accession numbers - not on brand loyalty. All compounds discussed are research-use-only (RUO) chemicals, not for human or veterinary use, and nothing here is medical advice, a dosing protocol, or a treatment recommendation.